who owns the patent for retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation who owns the patent for

The decision sits with your prescriber and depends on whether youre breastfeeding, your postpartum recovery, and your wider clinical picture

Proteomic analysis Proteomic analysis revealed further insights into the mechanisms underlying the metabolic and reproductive benefits of GLP-1RAs

Semaglutide is a GLP-1 receptor agonist already approved separately as Ozempic, Wegovy, and Rybelsus depending on formulation and indication

Contrastingly, no statistically significant signal values were observed in other age groups, including younger adults, adults, and the elderly, based on both ROR and EBGM05

The 23-time Grand Slam champion shared her decision to take a weight loss drug following the birth of her second daughter as part of her partnership with health care company Ro, for which she is a paid spokesperson